EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Development and validation of a routine urinalysis-based risk stratification model for IgA nephropathy in a multicenter real-world hospital population

Chi Wang, Wan He, QingYuan Zheng, Yuan Zhong, Meng Tang, ChunYing Zhang, Yong He

Frontiers in Nephrology · 11.08.2026 · 6

DOI: 10.3389/fneph.2026.1826486 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Nephrology, online erschienen am 11.08.2026. Verfasst von Chi Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, China. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Sichuan Provincial Science and Technology Support Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

IgA nephropathy (IgAN) is the most common primary glomerular disease worldwide. Routine urinalysis is universally accessible but underutilized for IgAN risk stratification. This study aimed to develop and validate a urinalysis-based risk stratification model for IgAN in a multicenter real-world hospital population.

Methods

This retrospective multicenter study was based on routine urinalysis records from 8 hospitals. A total of 354 patients had biopsy-confirmed primary IgAN, and 18,002 controls had no documented IgAN diagnosis after electronic medical record (EMR) review. The dataset was randomly divided into a training cohort (70%) and a hold-out validation cohort (30%). LASSO penalized logistic regression was used for variable selection. Model performance was evaluated by discrimination, calibration, and decision curve analysis (DCA). Bootstrap validation with 1000 resamplings was performed. An 8-variable simplified model was additionally developed.

Results

LASSO regression selected 13 variables for the primary full model. The primary model achieved an AUC of 0.849 (95% CI: 0.824–0.873) in the training cohort and 0.861 (95% CI: 0.833–0.890) in the validation cohort. Calibration was good in the training cohort (Brier score = 0.017), while moderate calibration deviation was observed in the validation cohort (Brier score = 0.020). The model yielded a high negative predictive value (>0.99). The 8-variable simplified model retained favorable discrimination with a validation AUC of 0.840.

Conclusions

This routine urinalysis-based model may serve as an accessible laboratory-based risk stratification tool for identifying patients with relatively low or elevated predicted probability of IgAN in real-world hospital settings. It should be interpreted as an adjunct to clinical evaluation rather than as a stand-alone diagnostic test or replacement for renal biopsy.

Schlagwörter

Stichwörter der Autor:innen

IgA nephropathyLASSO regressionprediction modelreal-world datarisk stratificationroutine urinalysis

Autor:innen und Institutionen

  • Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, China.
  • Sichuan Clinical Research Center for Laboratory Medicine, Chengdu, China.
  • Clinical Laboratory Medicine Research Center of West China Hospital, Chengdu, China.

Förderung

  • Sichuan Provincial Science and Technology Support Program

Zitieren

APA

Wang, C., He, W., Zheng, Q., Zhong, Y., Tang, M., Zhang, C., & He, Y. (2026). Development and validation of a routine urinalysis-based risk stratification model for IgA nephropathy in a multicenter real-world hospital population. Frontiers in Nephrology, 6. https://doi.org/10.3389/fneph.2026.1826486

Vancouver

Wang C, He W, Zheng Q, Zhong Y, Tang M, Zhang C, et al. Development and validation of a routine urinalysis-based risk stratification model for IgA nephropathy in a multicenter real-world hospital population. Frontiers in Nephrology. 2026;6. doi:10.3389/fneph.2026.1826486

BibTeX
@article{Wang2026,
  author = {Wang, Chi and He, Wan and Zheng, QingYuan and Zhong, Yuan and Tang, Meng and Zhang, ChunYing and He, Yong},
  title = {Development and validation of a routine urinalysis-based risk stratification model for IgA nephropathy in a multicenter real-world hospital population},
  journal = {Frontiers in Nephrology},
  year = {2026},
  volume = {6},
  doi = {10.3389/fneph.2026.1826486}
}
Kostenlos starten →